Clinical Trial: Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients
Study Status: Completed
Recruit Status: RECRUITING
Condition: Kidney Transplant
Study Type: INTERVENTIONAL
Official Title: Safety of Intraarterial Infusion of Adipose Tissue-derived Mesenchymal Stromal Cells to Treat Antibody-mediated and Cellular Rejection in Adult Kidney Transplant Recipients (AMSCAR)
Brief Summary:
This research study is being done to learn if an experimental treatment of infusing allogeneic adipose-derived mesenchymal stromal cells (allo-A-MSC ) directly into the renal artery is safe and can help reduce inflammation in the transplanted kidney and treat rejection.
Read more